Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Plos Biology|February 29, 2024
CD38 promotes hematopoietic stem cell dormancyLiliia Ibneeva, Sumeet Pal Singh, Anupam Sinha, et al.
Frontiers in Immunology|October 31, 2022
Perturbations of mesenchymal stromal cells after allogeneic hematopoietic cell transplantation predispose for bone marrow graft-versus-host-diseaseThomas Krüger, Rebekka Wehner, Maik Herbig, et al.
Biorxiv : the Preprint Server for Biology|December 9, 2024
Inflammatory Mesenchymal Stromal Cells and IFN-responsive T cells are key mediators of human bone marrow niche remodeling in CHIP and MDSKarin D Prummel, Kevin Woods, Maksim Kholmatov, et al.
Frontiers in Immunology|April 16, 2019
Neoadjuvant Radiochemotherapy Significantly Alters the Phenotype of Plasmacytoid Dendritic Cells and 6-Sulfo LacNAc+ Monocytes in Rectal CancerFelix Wagner, Ulrike Hölig, Friederike Wilczkowski, et al.
Journal of Translational Medicine|December 17, 2025
Automated GMP-compatible production of universal CAR Tregs for organ-targeted tolerance inductionKavitha Lakshmi, Alexandra von Jutrzenka-Trzebiatowski, Liliana Loureiro, et al.
EMBO Molecular Medicine|July 3, 2026
Patient-derived resources for decoding and targeting brain metastases ecosystemsManuel Valiente, Lal Era Aydoğan, Nisan Feigin, et al.
Nature Communications|November 18, 2025
Inflammatory stromal and T cells mediate human bone marrow niche remodeling in clonal hematopoiesis and myelodysplasiaKarin D Prummel, Kevin Woods, Maksim Kholmatov, et al.
Immunity|April 1, 2022
Microbiota-dependent activation of the myeloid calcineurin-NFAT pathway inhibits B7H3- and B7H4-dependent anti-tumor immunity in colorectal cancerKenneth Peuker, Anne Strigli, Daniele V F Tauriello, et al.
Blood|December 8, 2025
Azacitidine to treat measurable residual disease in patients with MDS/AML: final long-term results of the RELAZA2 trialAnne Sophie Platzbecker, Julia Annabell Georgi, Jan Moritz Middeke, et al.
Journal for Immunotherapy of Cancer|November 16, 2019
A new synthetic toll-like receptor 1/2 ligand is an efficient adjuvant for peptide vaccination in a human volunteerHans-Georg Rammensee, Karl-Heinz Wiesmüller, P Anoop Chandran, et al.
Pageof 7